First class action lawsuits target major U.S. cannabis companies

By AI, Created 10:21 AM UTC, May 20, 2026, /AGP/ – A group of law firms has filed what they call the first class action lawsuits against several major cannabis companies in Illinois and Connecticut, accusing them of misleading consumers about the health risks of recreational marijuana. The cases seek damages and changes to industry practices across a dozen states.

Why it matters: - The lawsuits could reshape how major cannabis brands market recreational products and disclose health risks. - The cases seek money for consumers and broader changes to industry practices. - The complaints could also test whether marijuana marketing can be challenged as consumer fraud, racketeering, and common-law fraud across multiple states.

What happened: - Weitz & Luxenberg, Burke Law Group, Franks Gerkin Ponitz & Greeley, and Pawa Law Group filed class action lawsuits against Cresco, Curaleaf, Green Thumb Industries, and Verano. - The firms filed the cases in federal and state courts in Illinois and Connecticut on May 6, 2026. - The Illinois federal case is in the Northern District of Illinois, case No. 26-cv-50184. - The Connecticut federal case is in the District of Connecticut, case No. 3:26-cv-684. - The firms described the cases as first-of-their-kind class actions against major U.S. cannabis companies.

The details: - The Illinois complaint runs more than 300 pages. - The Illinois case includes 30 class representatives. - The proposed class covers consumers in Arizona, Connecticut, Illinois, Maryland, Massachusetts, Michigan, Minnesota, Nevada, New Jersey, New York, Ohio, Rhode Island, and Virginia. - The complaints allege the companies marketed recreational cannabis as medicinal to drive billions in revenue. - The filings also allege the companies failed to warn consumers about health risks and potentially catastrophic dangers. - The lawsuits claim recreational cannabis is not medicine and is not safe. - The complaints allege the industry tried to suppress those risks through promotion, public relations, and marketing. - The Illinois complaint alleges violations of state consumer protection laws, common law fraud, RICO, and other claims. - The lawsuits allege cannabis can cause serious mental health disorders, including schizophrenia, suicidal ideation, and depression. - The complaints also allege cannabis use can contribute to life-threatening conditions such as heart attacks. - The plaintiffs are seeking financial damages for consumers who say they did not know what the defendants knew at the time of purchase. - The lawsuits also seek meaningful changes to the defendants’ practices.

Between the lines: - The filing turns a long-running public health debate into a high-stakes consumer litigation campaign. - By naming some of the largest U.S. cannabis companies, the plaintiffs are targeting the industry’s most visible brands and marketing channels. - Support from public health-focused marijuana policy groups may help frame the cases as part of a broader warning effort, not just a private damages fight.

What’s next: - The cases are likely to move into early motions and class certification fights. - The companies will have a chance to challenge the allegations, the proposed classes, and the legal theories. - If the lawsuits advance, they could pressure cannabis companies to change labeling, advertising, and risk disclosures.

The bottom line: - The new lawsuits aim to make marijuana companies answer for how they marketed recreational cannabis and what they told consumers about the risks.